Clinical Trial Update: Rituximab Objective Outcome Measures Trial in SLE [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on rituximab for systemic lupus erythematosus with arthritis is reported, but current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University of Leeds | Conditions: Systemic Lupus Erythematosus Arthritis | Phase 2 | Status: UNKNOWN